379
Participants
Start Date
October 16, 2023
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2026
RBT-1
Intravenous administration
Placebo
Intravenous administration
New York Presbyterian-Queens, Flushing
Research Site, Washington D.C.
Research Site, Charlottesville
Research Site, Winston-Salem
Research Site, Raleigh
Research Site, Atlanta
Research Site, Athens
Research Site, Gainesville
Research Site, Atlantis
Research Site, Huntsville
Research Site, Nashville
Research Site, Toledo
Research Site, Cleveland
Research Site, Indianapolis
Research Site, Indianapolis
Research Site, Fort Wayne
Research Site, Royal Oak
Research Site, Ann Arbor
Research Site, Midland
Research Site, Lansing
Research Site, Rochester
Research Site, St Louis
Research Site, Kansas City
Research Site, Dallas
Research Site, Houston
Research Site, San Antonio
Research Site, San Francisco
Research Site, Stanford
Research Site, Boston
Research Site, Kelowna
Research Site, Saint John
Research Site, St. John's
Research Site, Hamilton
Research Site, Kingston
Research Site, Montreal
Research Site, Montreal
Research Site, Montreal
Research Site, Montreal
Research Site, Québec
Renibus Therapeutics, Inc.
INDUSTRY